Published in N Engl J Med on January 12, 2006
Aerosol Cyclosporine for Prevention of Lung Rejection | NCT00268515
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients | NCT01650545
CIS001 Extension Study of Cyclosporine Inhalation Solution (CIS002) | NCT00938236
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients | NCT00633373
Using regression models to analyze randomized trials: asymptotically valid hypothesis tests despite incorrectly specified models. Biometrics (2009) 1.77
Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc (2009) 1.30
State of progress in treating cystic fibrosis respiratory disease. BMC Med (2012) 0.96
Immunosuppression for lung transplantation. Front Biosci (Landmark Ed) (2009) 0.95
Immunosuppression in lung transplantation. J Thorac Dis (2014) 0.92
Technology and outcomes assessment in lung transplantation. Proc Am Thorac Soc (2009) 0.87
MegaRibavirin aerosol for the treatment of influenza A virus infections in mice. Antiviral Res (2008) 0.85
A review of bronchiolitis obliterans syndrome and therapeutic strategies. J Cardiothorac Surg (2011) 0.83
Polarized alloantigen presentation by airway epithelial cells contributes to direct CD8+ T cell activation in the airway. Am J Respir Cell Mol Biol (2011) 0.82
Characterization of a cyclosporine solid dispersion for inhalation. AAPS J (2007) 0.82
What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81
Inhaled cyclosporine and pulmonary function in lung transplant recipients. J Aerosol Med Pulm Drug Deliv (2010) 0.81
Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential. Clin Dev Immunol (2013) 0.79
In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization. AAPS PharmSciTech (2014) 0.78
Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease. Lung (2011) 0.77
Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges. Cent Eur J Immunol (2014) 0.77
Lung transplantation. F1000Prime Rep (2013) 0.77
Lung transplant immunosuppression - time for a new approach? Expert Rev Clin Immunol (2014) 0.76
Lung deposition and pharmacokinetics of nebulized cyclosporine in lung transplant patients. J Aerosol Med Pulm Drug Deliv (2013) 0.75
A Critical Care and Transplantation-Based Approach to Acute Respiratory Failure after Hematopoietic Stem Cell Transplantation in Children. Biol Blood Marrow Transplant (2015) 0.75
[Inhaled cyclosporin suppresses chronic projection following lung transplantation]. Pneumologie (2006) 0.75
Inhaled cyclosporine in lung transplantation. N Engl J Med (2006) 0.75
Inhaled cyclosporine--a breath of fresh air? N Engl J Med (2006) 0.75
Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09
Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90
Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 3.02
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database. J Thorac Cardiovasc Surg (2009) 2.87
Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit. Am J Respir Crit Care Med (2014) 2.80
Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One (2008) 2.67
Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med (2008) 2.65
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2009) 2.43
The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38
Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg (2008) 2.35
Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int (2009) 2.35
Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2009) 2.35
Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. Pharmacotherapy (2008) 2.34
VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30
Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion (2006) 2.26
Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24
New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J Clin Pharmacol (2008) 2.23
Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J Clin Invest (2004) 2.20
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant (2004) 2.09
A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C. Liver Transpl (2002) 2.07
Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease. Liver Transpl (2006) 2.02
National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01
Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator. Mol Endocrinol (2003) 1.96
Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93
Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology (2004) 1.92
EVAHEART: an implantable centrifugal blood pump for long-term circulatory support. Jpn J Thorac Cardiovasc Surg (2002) 1.90
Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile. Am J Clin Pathol (2009) 1.86
Pretransplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl (2005) 1.79
Ambulatory veno-venous extracorporeal membrane oxygenation: innovation and pitfalls. J Thorac Cardiovasc Surg (2011) 1.79
Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant (2009) 1.78
Aortic valve bypass for the high-risk patient with aortic stenosis. Ann Thorac Surg (2006) 1.75
Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT. J Heart Lung Transplant (2013) 1.71
Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med (2003) 1.69
Intermediate-term outcomes of surgical atrial fibrillation correction with the CryoMaze procedure. Ann Thorac Surg (2009) 1.65
Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. Ann Thorac Surg (2006) 1.63
In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology (2006) 1.63
Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody. Transplantation (2008) 1.62
Influence of hospital procedural volume on care process and mortality for patients undergoing elective surgery for mitral regurgitation. Circulation (2007) 1.62
Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61
Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58
J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg (2010) 1.57
Progressive primary sclerosing cholangitis requiring liver transplantation is associated with reduced need for colectomy in patients with ulcerative colitis. Clin Gastroenterol Hepatol (2012) 1.56
Striving for normalcy: symptoms and the threat of rejection after lung transplantation. Soc Sci Med (2004) 1.56
Effects of continuous flow left ventricular assist device support on skin tissue microcirculation and aortic hemodynamics. ASAIO J (2003) 1.54
Platelet function tests predict bleeding and thrombotic events after off-pump coronary bypass grafting. Eur J Cardiothorac Surg (2005) 1.53
Thirty-day in-vivo performance of a wearable artificial pump-lung for ambulatory respiratory support. Ann Thorac Surg (2011) 1.52
Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52
Effect of aneurysm on the tensile strength and biomechanical behavior of the ascending thoracic aorta. Ann Thorac Surg (2003) 1.51
Extrapolation of adult data and other data in pediatric drug-development programs. Pediatrics (2011) 1.50
The development and testing of a laboratory information system-driven tool for pre-sign-out quality assurance of random surgical pathology reports. Am J Clin Pathol (2010) 1.50
Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg (2005) 1.49
Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48
Endovascular stenting for traumatic aortic injury: an emerging new standard of care. Ann Thorac Surg (2008) 1.47
HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46
Hypercoagulability affecting early vein graft patency does not exist after off-pump coronary artery bypass. J Cardiothorac Vasc Anesth (2005) 1.45
Hepatic stellate cells regulate immune response by way of induction of myeloid suppressor cells in mice. Hepatology (2011) 1.44
Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43
Growing experience with extracorporeal membrane oxygenation as a bridge to lung transplantation. ASAIO J (2012) 1.43
Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol (2003) 1.43
The use of lung donors older than 55 years: a review of the United Network of Organ Sharing database. J Heart Lung Transplant (2013) 1.42
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Y-piece temperature and humidification during mechanical ventilation. Respir Care (2009) 1.38
Blow-by as potential therapy for uncooperative children: an in-vitro study. Respir Care (2012) 1.38
Ambulatory extracorporeal membrane oxygenation: a new approach for bridge-to-lung transplantation. J Thorac Cardiovasc Surg (2010) 1.37
Blunt aortic injury. N Engl J Med (2008) 1.35
Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis (2009) 1.34
Significance of EGFR protein expression and gene amplification in non-small cell lung carcinoma. Am J Clin Pathol (2006) 1.34
Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation (2005) 1.32
Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. J Immunol (2002) 1.32
Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30
Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant (2007) 1.30
Therapeutic antioxidant medical gas. J Clin Biochem Nutr (2008) 1.29
Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg (2010) 1.29
Blood soluble drag-reducing polymers prevent lethality from hemorrhagic shock in acute animal experiments. Biorheology (2004) 1.29
Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artif Organs (2006) 1.28
Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med (2003) 1.28
Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant (2003) 1.28
HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27